发明名称 |
COMBINATION COMPRISING AN INSULIN SECRETION ENHANCER AND AN ACTIVE INGREDIENT SELECTED FROM HMG-CO-A REDUCTASE INHIBITORS AND ACE INHIBITORS |
摘要 |
The present invention relates to a combination, especially a pharmaceutical composition, comprising (a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof and (b) at least one of the active ingredients selected from the group consisting of (i) HMG-Co-A reductase inhibitors or a pharmaceutically acceptable salt thereof; and (ii) ACE inhibitors or a pharmaceutically acceptable salt thereof; and, in case of a pharmaceutical composition, a pharmaceutically acceptable carrier. |
申请公布号 |
WO0215892(A3) |
申请公布日期 |
2003.09.04 |
申请号 |
WO2001EP09586 |
申请日期 |
2001.08.20 |
申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH;ALLISON, MALCOLM;GATLIN, MARJORIE, REGAN |
发明人 |
ALLISON, MALCOLM;GATLIN, MARJORIE, REGAN |
分类号 |
A61K31/198;A61K31/405;A61K31/55;A61K45/06;A61P1/04;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/00;A61P7/04;A61P9/00;A61P9/10;A61P9/12;A61P13/00;A61P15/00;A61P15/10;A61P17/00;A61P25/00;A61P27/02;A61P27/12 |
主分类号 |
A61K31/198 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|